All In MedTech

Device Trial Radar · NCT07352085

Exoskeleton-assisted Neurorehabilitation

Exoskeleton-assisted Neurorehabilitation: Current Perspectives and Future Directions - A Pilot Study

Last checked: Nov 19, 2026Latest source record: Jan 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

5

Actual

Start

Jun 1, 2024

Primary completion

Feb 28, 2025

Study completion Feb 28, 2025

Sponsor

Lead sponsor
Somogy Megyei Kaposi Mór Teaching HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

* Objective assesment of the feasibility of integrating the Ekso Bionics - Ekso NR device into outpatient care * Objective assesment of quality of life, functionality and clinical symptomps of patients with stroke, cerebellar ataxia, spinal cord injury, and spastic paraparesis * Comparison of measured data and follow-up of changes in relation to themselves and each other * Analyzing the effects of the exoskeleton among the patients * Assessing the safety, possible side effects and tolerability of the EksoNR

Conditions

  • Stroke
  • Spinal Cord Injuries (Complete and Incomplete)
  • Cerebellar Ataxia
  • Spastic Paraplegia

Interventions

  • Gait training with exoskeletonDevice

    EksoNR is a wearable, battery-powered bionic exoskeleton that enables individuals with neurological or muscular injuries, lower limb weakness, paralysis, or gait disorders to stand and walk on flat surfaces. The hip and knee joints are powered by motors, and all movements are performed either by the patient's specific movements or by using an external controller. The robot's functions can be adjusted to determine the level of assistance the device provides to the patient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Functional Independence Measure (FIM)Time frame: 4 weeks
  2. Barthel Index (BI)Time frame: 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Somogy County Kaposi Mór Teaching Hospital

    Kaposvár, Somogy County, Hungary

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.